Does insulin resistance alter delta-5 and delta-6 desaturase activity and shift omega‑3/omega‑6 processing?

Delta-5 desaturase (D5D) and delta-6 desaturase (D6D) act as metabolic gatekeepers, converting dietary plant-based fats (LA and ALA) into biologically active long-chain polyunsaturated fatty acids (LC-PUFAs). Extensive research confirms that insulin resistance and hyperinsulinemia fundamentally alter these enzymatic pathways, shifting how the body processes both omega-6 and omega-3 fatty acids.

Clinical evidence and metabolic associations

Research consistently demonstrates that elevated activities of D5D and D6D are potent biomarkers for insulin resistance and metabolic dysfunction.

• Insulin resistance markers: Higher estimated activities of both D5D and D6D are strongly associated with impaired insulin sensitivity and increased risk of type 2 diabetes across human and animal models.
• Inflammatory profiles: In insulin-resistant states, the enzymatic flux shifts toward increased production of arachidonic acid (AA, omega-6). High levels of AA-derived metabolites are linked to systemic inflammation and exacerbated metabolic distress.
• Interventional findings: Studies show that selectively inhibiting D5D can improve insulin sensitivity and reduce adipose tissue inflammation, highlighting a causative link between desaturase activity and metabolic health.

Mechanistic pathways

The primary driver of these enzymatic changes is the transcription factor SREBP-1c, which is highly sensitive to insulin levels.

• SREBP-1c activation: In hyperinsulinemic states, excess insulin triggers the activation of SREBP-1c. This factor directly upregulates the expression of the FADS1 (D5D) and FADS2 (D6D) genes.
• Enzymatic competition: Both omega-6 and omega-3 fatty acids compete for the same D5D and D6D enzymes. When these enzymes are overactive—particularly in a diet high in omega-6 precursors—the body prioritizes the production of pro-inflammatory omega-6 derivatives, which can outcompete and limit the conversion of anti-inflammatory omega-3 precursors (EPA and DHA).
• Genetic influence: Genetic variations, such as the rs174537 SNP in the FADS gene cluster, can further modulate these rates, determining how efficiently an individual converts precursors into long-chain fatty acids.

Bottom line

Insulin resistance and high insulin levels directly increase desaturase activity via SREBP-1c activation. This creates a metabolic feedback loop that prioritizes the production of inflammatory omega-6 metabolites while potentially hindering omega-3 processing, further driving systemic inflammation and insulin resistance.